Alisol B 23-acetate broadly inhibits coronavirus through blocking virus entry and suppresses proinflammatory T cells responses for the treatment of COVID-19

Peiris, 2003, Coronavirus as a possible cause of severe acute respiratory syndrome, Lancet (London, England), 361, 1319, 10.1016/S0140-6736(03)13077-2 Zaki, 2012, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N Engl J Med, 367, 1814, 10.1056/NEJMoa1211721 Chan, 2015, Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease, Clin Microbiol Rev, 28, 465, 10.1128/CMR.00102-14 Orgnaztion WH. Coronavirus Disease (COVID-19) Situation Reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports, 2020. Chan, 2020, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet, 395, 514, 10.1016/S0140-6736(20)30154-9 Torjesen, 2021, Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear, BMJ, 375 Williamson, 2020, Factors associated with COVID-19-related death using OpenSAFELY, Nature, 584, 430, 10.1038/s41586-020-2521-4 Ghosh, 2022, A review on evolution of emerging SARS-CoV-2 variants based on spike glycoprotein, Int Immunopharmacol, 10.1016/j.intimp.2022.108565 Han, 2022, Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2, Cell, 185, 630, 10.1016/j.cell.2022.01.001 Mannar, 2022, SARS-CoV-2 omicron variant: antibody evasion and cryo-EM structure of spike protein–ACE2 complex, Science, 375, 760, 10.1126/science.abn7760 Gottlieb, 2022, Early remdesivir to prevent progression to severe Covid-19 in outpatients, N Engl J Med, 386, 305, 10.1056/NEJMoa2116846 Ader, 2022, Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial, Lancet Infect Dis, 22, 209, 10.1016/S1473-3099(21)00485-0 Angamo, 2022, Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis, Infection, 50, 27, 10.1007/s15010-021-01671-0 Cao, 2020, A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19, N Engl J Med, 382, 1787, 10.1056/NEJMoa2001282 Goulao B, Hood K, Dahly D. Statistical review of Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial. 2020. Investigators, 2021, Interleukin-6 receptor antagonists in critically ill patients with covid-19, N Engl J Med, 384, 1491, 10.1056/NEJMoa2100433 Owen, 2021, An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19, Science, eabl4784 Jayk Bernal, 2021, Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients, N Engl J Med, 386, 509, 10.1056/NEJMoa2116044 Singh, 2022, An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19, Diabetes Metab Syndr, 16, 10.1016/j.dsx.2022.102396 Dai EY et al. Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir. medRxiv, 2022: p. 2022.08.04.22278378. Wang, 2022, Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5, Nature Wang, 2022, Effectiveness and safety research of Qingfei Paidu (QFPD) in treatment of COVID-19: an up-to-date systematic review and meta-analysis, Chin Med, 17, 1, 10.4236/cm.2022.131001 Li, 2022, Identification of phytochemicals in Qingfei Paidu decoction for the treatment of coronavirus disease 2019 by targeting the virus-host interactome, Biomed Pharmacother, 156, 10.1016/j.biopha.2022.113946 Yang, 2020, Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): in silico and experimental study, Pharmacol Res, 157, 10.1016/j.phrs.2020.104820 Banerjee, 2022, Glycyrrhizin as a promising kryptonite against SARS-CoV-2: clinical, experimental, and theoretical evidences, J Mol Struct Yi, 2022, Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection, J Adv Res, 36, 201, 10.1016/j.jare.2021.11.012 Fiore, 2008, Antiviral effects of Glycyrrhiza species, Phytother Res, 22, 141, 10.1002/ptr.2295 Zhong, 2020, Potential targets for treatment of coronavirus disease 2019 (COVID-19): a review of Qing-Fei-Pai-Du-Tang and its major herbs, Am J Chin Med, 48, 1051, 10.1142/S0192415X20500512 Chen, 2020, Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: applications for natural product efficacy with omics and systemic biology, Pharmacol Res, 158, 10.1016/j.phrs.2020.104877 Chen, 2020, Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming, Biomed Pharmacother, 129, 10.1016/j.biopha.2020.110281 Xu, 2017, Pharmacokinetics and tissue distribution of five major triterpenoids after oral administration of Rhizoma Alismatis extract to rats using ultra high-performance liquid chromatography–tandem mass spectrometry, J Pharm Biomed Anal, 146, 314, 10.1016/j.jpba.2017.09.009 Jin, 2012, A new triterpenoid from Alisma orientale and their antibacterial effect, Arch Pharm Res, 35, 1919, 10.1007/s12272-012-1108-5 Zhu H-C et al. Alisol B 23-acetate ameliorates azoxymethane/dextran sodium sulfate-induced male murine colitis-associated colorectal cancer via modulating the composition of gut microbiota and improving intestinal barrier. Front Cell Infect Microbiol 2021: p. 358. Meng, 2015, Protective effects of alisol B 23-acetate from edible botanical Rhizoma alismatis against carbon tetrachloride-induced hepatotoxicity in mice, Food Funct, 6, 1241, 10.1039/C5FO00082C Jiang, 2006, A new triterpene and anti-hepatitis B virus active compounds from Alisma orientalis, Planta Med, 72, 951, 10.1055/s-2006-947178 Han CW, Choi J-Y. Therapeutic effect of alisol acetate B on lipopolysaccharide-induced acute lung injury, in DSEPSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND ACUTE LUNG INJURY. 2014, American Thoracic Society. p. A5726-A5726. Shin, 2014, The anti-inflammatory effects of Alisma herb extract on allergic asthma mouse model, Mol Cell Toxicol, 10, 197, 10.1007/s13273-014-0021-z Chan, 2020, Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility, Clin Infect Dis, 71, 2428 Lu, 2021, Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients, medRxiv Yuan, 2021, Clofazimine broadly inhibits coronaviruses including SARS-CoV-2, Nature, 593, 418, 10.1038/s41586-021-03431-4 Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 Huang, 2020, Conformational dynamics of the helix 10 region as an allosteric site in class A β-lactamase inhibitory binding, J Am Chem Soc, 142, 13756, 10.1021/jacs.0c04088 Lin, 2019, IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren’s syndrome, Cell Mol Immunol, 16, 921, 10.1038/s41423-019-0227-z Yuan, 2019, SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target, Nat Commun, 10, 120, 10.1038/s41467-018-08015-x Yuan, 2022, Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters, Science, 377, 428, 10.1126/science.abn8939 Peng, 2016, A rationally designed rhodamine-based fluorescent probe for molecular imaging of peroxynitrite in live cells and tissues, Chem Sci, 7, 5407, 10.1039/C6SC00012F Bhatia, 2004, Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome, J Pathol: J Pathol Soc Great Britain and Ireland, 202, 145, 10.1002/path.1491 Blaser, 2016, TNF and ROS crosstalk in inflammation, Trends Cell Biol, 26, 249, 10.1016/j.tcb.2015.12.002 Laforge, 2020, Tissue damage from neutrophil-induced oxidative stress in COVID-19, Nat Rev Immunol, 20, 515, 10.1038/s41577-020-0407-1 Delorey, 2021, COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets, Nature, 595, 107, 10.1038/s41586-021-03570-8 Grant, 2021, Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia, Nature, 590, 635, 10.1038/s41586-020-03148-w Yeung, 2021, Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system, Cell, 184, 2212, 10.1016/j.cell.2021.02.053 Cai, 2020, Distinct conformational states of SARS-CoV-2 spike protein, Science, 369, 1586, 10.1126/science.abd4251 Li, 2022, Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1, Cell, 185, 2952, 10.1016/j.cell.2022.06.023 Hong, 2022, Molecular basis of receptor binding and antibody neutralization of Omicron, Nature, 604, 546, 10.1038/s41586-022-04581-9 Towler, 2004, ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis *, J Biol Chem, 279, 17996, 10.1074/jbc.M311191200 Wang, 2020, Structural and functional basis of SARS-CoV-2 entry by using human ACE2, Cell, 181, 894, 10.1016/j.cell.2020.03.045 Shang, 2020, Structural basis of receptor recognition by SARS-CoV-2, Nature, 581, 221, 10.1038/s41586-020-2179-y Lan, 2020, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor, Nature, 581, 215, 10.1038/s41586-020-2180-5 Shukla, 2021, Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update, High Blood Pressure & Cardiovascular Prevention, 28, 129, 10.1007/s40292-021-00439-9 Ravichandran, 2021, SARS-CoV-2 and hypertension, Physiol Rep, 9, e14800, 10.14814/phy2.14800 Chen, 2020, Alisol B 23-acetate attenuates CKD progression by regulating the renin–angiotensin system and gut–kidney axis, Therapeutic Adv Chronic Disease, 11, 10.1177/2040622320920025 Matsuyama, 2010, Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2, J Virol, 84, 12658, 10.1128/JVI.01542-10 Shereen, 2020, COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses, J Adv Res, 24, 91, 10.1016/j.jare.2020.03.005 Zhao, 2022, SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells, Emerging Microbes Infect, 11, 277, 10.1080/22221751.2021.2023329 Ou, 2020, Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV, Nat Commun, 11, 1620, 10.1038/s41467-020-15562-9 Cantuti-Castelvetri, 2020, Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity, Science, 370, 856, 10.1126/science.abd2985 Bao, 2020, The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice, Nature, 583, 830, 10.1038/s41586-020-2312-y Imai M et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proceedings of the National Academy of Sciences, 2020;117(28): 16587–16595. Askani, 2022, Computed tomographic imaging features of COVID-19 pneumonia caused by the delta (B.1.617.2) and omicron (B.1.1.529) variant in a German nested cohort pilot study group, Tomography, 8, 2435, 10.3390/tomography8050202 Hojyo, 2020, How COVID-19 induces cytokine storm with high mortality, Inflam Regenerat, 40, 37, 10.1186/s41232-020-00146-3 Tang, 2020, Cytokine storm in COVID-19: the current evidence and treatment strategies, Front Immunol, 11, 10.3389/fimmu.2020.01708 Gattinoni, 2020, COVID-19 does not lead to a “typical” acute respiratory distress syndrome, Am J Respir Crit Care Med, 201, 1299, 10.1164/rccm.202003-0817LE Pacha, 2020, COVID-19: a case for inhibiting IL-17?, Nat Rev Immunol, 20, 345, 10.1038/s41577-020-0328-z Cao, 2020, COVID-19: immunopathology and its implications for therapy, Nat Rev Immunol, 20, 269, 10.1038/s41577-020-0308-3 Kridin, 2022, Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors, J Dermatol Treat, 1 Conti, 2020, Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies, J Biol Regul Homeost Agents, 34, 1 Cavalli, 2020, Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study, The Lancet Rheumatology, 2, e325, 10.1016/S2665-9913(20)30127-2 Bastard, 2020, Autoantibodies against type I IFNs in patients with life-threatening COVID-19, Science, 370, 10.1126/science.abd4585 Karki, 2021, Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 Infection and CYTOKINE shock syndromes, Cell, 184, 149, 10.1016/j.cell.2020.11.025 Ghosh, 2021, Neutralization of IL-17 and treatment with IL-2 protects septic arthritis by regulating free radical production and antioxidant enzymes in Th17 and Tregs: an immunomodulatory TLR2 versus TNFR response, Cell Immunol, 370, 10.1016/j.cellimm.2021.104441 Saheb Sharif-Askari, 2021, Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection, Free Radic Biol Med, 172, 688, 10.1016/j.freeradbiomed.2021.06.018 Radzikowska, 2020, Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors, Allergy, 75, 2829, 10.1111/all.14429 Wu, 2020, Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China, Cell Host Microbe, 27, 325, 10.1016/j.chom.2020.02.001 Ziegler, 2020, SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues, Cell, 181, 1016, 10.1016/j.cell.2020.04.035 Shen, 2022, ACE2-independent infection of T lymphocytes by SARS-CoV-2, Signal Transduct Target Ther, 7, 83, 10.1038/s41392-022-00919-x Vankadari, 2020, Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26, Emerging Microbes Infect, 9, 601, 10.1080/22221751.2020.1739565 Pushkarsky T. et al. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc Natl Acad Sci, 2001;98(11): p. 6360-6365. Zhang, 2014, A UFLC/MS/MS method for simultaneous quantitation of alisol A and alisol B 23-acetate from Alisma orientale (Sam.) Juz. in rat plasma, Asian J Pharm Sci, 9, 279, 10.1016/j.ajps.2014.08.001 Meng, 2017, Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation, Acta Pharmacol Sin, 38, 69, 10.1038/aps.2016.119